Literature DB >> 20975842

The protein cargo of HDL: implications for vascular wall biology and therapeutics.

Jay W Heinecke1.   

Abstract

High-density lipoprotein (HDL) is proposed to inhibit atherosclerosis via a number of different pathways, including promotion of reverse cholesterol transport and inhibition of inflammation. However, studies in both mice and humans suggest that quantifying HDL-cholesterol (HDL-C) levels provide limited information regarding the cardioprotective effects of HDL. This article briefly reviews current thinking regarding the functional and cardioprotective effects of HDL and the role of the HDL proteome in these processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20975842      PMCID: PMC2959168          DOI: 10.1016/j.jacl.2010.08.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  27 in total

Review 1.  Regulation and mechanisms of macrophage cholesterol efflux.

Authors:  Alan R Tall; Philippe Costet; Nan Wang
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

3.  ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.

Authors:  Laurent Yvan-Charvet; Tamara Pagler; Emmanuel L Gautier; Serine Avagyan; Read L Siry; Seongah Han; Carrie L Welch; Nan Wang; Gwendalyn J Randolph; Hans W Snoeck; Alan R Tall
Journal:  Science       Date:  2010-05-20       Impact factor: 47.728

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

5.  Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.

Authors:  Robert J Aiello; Dominique Brees; Patricia-Ann Bourassa; Lori Royer; Saralyn Lindsey; Timothy Coskran; Mehrdad Haghpassand; Omar L Francone
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

6.  VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.

Authors:  F M Sacks; P Alaupovic; L A Moye; T G Cole; B Sussex; M J Stampfer; M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

7.  Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.

Authors:  Miranda van Eck; I Sophie T Bos; Wolfgang E Kaminski; Evelyn Orsó; Gregor Rothe; Jaap Twisk; Alfred Böttcher; Edwin S Van Amersfoort; Trudy A Christiansen-Weber; Wai-Ping Fung-Leung; Theo J C Van Berkel; Gerd Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 8.  Role of complement activation in atherosclerosis.

Authors:  Riina Oksjoki; Petri T Kovanen; Markku O Pentikäinen
Journal:  Curr Opin Lipidol       Date:  2003-10       Impact factor: 4.776

9.  Increased ABCA1 activity protects against atherosclerosis.

Authors:  Roshni R Singaraja; Catherine Fievet; Graciela Castro; Erick R James; Nathalie Hennuyer; Susanne M Clee; Nagat Bissada; Jonathan C Choy; Jean-Charles Fruchart; Bruce M McManus; Bart Staels; Michael R Hayden
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

10.  Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells.

Authors:  Scott D Covey; Monty Krieger; Wei Wang; Marsha Penman; Bernardo L Trigatti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-26       Impact factor: 8.311

View more
  21 in total

Review 1.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 2.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

3.  Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.

Authors:  Nicholas M Frame; Olga Gursky
Journal:  FEBS Lett       Date:  2016-03-06       Impact factor: 4.124

4.  Association of high-density lipoprotein subclasses and incident coronary heart disease: The Jackson Heart and Framingham Offspring Cohort Studies.

Authors:  Parag H Joshi; Peter P Toth; Seth T Lirette; Michael E Griswold; Joseph M Massaro; Seth S Martin; Michael J Blaha; Krishnaji R Kulkarni; Arif A Khokhar; Adolfo Correa; Ralph B D'Agustino; Steven R Jones
Journal:  Eur J Prev Cardiol       Date:  2014-07-25       Impact factor: 7.804

Review 5.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

6.  Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL.

Authors:  Prediman K Shah
Journal:  Nat Rev Cardiol       Date:  2011-03-01       Impact factor: 32.419

Review 7.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

Review 8.  Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?

Authors:  Baohai Shao; Jay W Heinecke
Journal:  Expert Rev Proteomics       Date:  2017-11-13       Impact factor: 3.940

Review 9.  Inflammation and atherosclerosis: direct versus indirect mechanisms.

Authors:  Michael E Rosenfeld
Journal:  Curr Opin Pharmacol       Date:  2013-01-26       Impact factor: 5.547

Review 10.  Regulation of signal transduction by HDL.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  J Lipid Res       Date:  2013-05-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.